Amgen (AMGN) has been under pressure in recent days. Amgen stock faces a "big unknown risk" with their obesity shot. As a result, implied volatility has spiked to 52%. That's much higher than the previous high for implied volatility of 32% and puts the implied volatility (IV) percentile at 100% and an IV Rank of 100%. High volatility makes for good iron condors setups. We can place our short strikes much further away from the market than we normally could giving us a wider profit range. Let's look at how we might set up an iron condor on Amgen stock. (read more) ---- Top-line 52-week data from the phase II study on MariTide, a GLP-1 receptor candidate in overweight or obese adults, is expected in late 2024, which will be a key catalyst for the stock. (read more) GL/HF
You're probably right. Now that we have sanity restored to gov/HHS we won't need weight loss/control drugs. OTOH, FDA might be dissolved completely and so no need for pesky drug approval. Tough call. Thank God I do nothing but score touchdowns and women! I should be ok, lol.